Compare Modine Manufacturing Company (MOD) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Modine Manufacturing Company vs Tenet Healthcare Corporation — how do they compare? Modine Manufacturing Company trades at $181.56 (market cap $9.66B), while Tenet Healthcare Corporation trades at $263.78 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 2.2× Modine Manufacturing Company's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Modine Manufacturing Company nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Modine Manufacturing Company for 33 Days and Tenet Healthcare Corporation for 15 Days on average.
| MOD | THC | |
|---|---|---|
Market Cap | $9.66B | $20.98B |
Volume | 1,331,946 | 428,008 |
Sector | Industrials | Health |
52-Week High | $283.95 | $280.77 |
52-Week Low | $110.73 | $161.37 |
Typical Hold Time | 33 Days | 15 Days |
Enterprise Value | $10.09B | $32.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Modine Manufacturing (MOD) trades at $181.89, down 3.99% today amid a bearish technical signal, though it remains above key support at $177. The company recently completed a $946M spin-off of its Performance Technologies unit, a major corporate restructuring. Fundamentals show strong revenue growth to $3.4B in 2026 but declining net margins to 4.27%. Analysts maintain a bullish consensus with a $331.25 price target, citing momentum and growth potential despite near-term volatility.
Outlook: MOD offers growth exposure with analyst optimism but faces execution risks post-spin-off and margin pressure. The stock's high P/E of 67.87 suggests premium valuation, requiring sustained earnings beats to justify upside. Key risks include integration challenges and competitive pressures in thermal management markets.
Tenet Healthcare (THC) trades at $260.57, showing modest daily gains of 0.28% with strong technical support at $257 and resistance at $262. The stock demonstrates robust fundamentals with a P/E of 10.07, net income margin of 9.9%, and consistent earnings beats in recent quarters. Recent news highlights the upcoming Q3 2026 earnings release on October 29, 2026, while the company maintains strong cash flow generation of $3.54 billion from operations.
THC presents a compelling investment case with 81% analyst buy ratings and a $283.36 consensus price target representing 8.7% upside potential. The company's expanding capital return strategy and projected revenue growth to $22.6 billion in 2026 support bullish sentiment, though investors should monitor surgical volume trends and capital allocation sustainability as key risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Modine Manufacturing Company
Modine Manufacturing Company is a global leader in thermal management technology and solutions. The company engineers, manufactures, and markets heat transfer products for a wide range of applications across the automotive, commercial, industrial, and HVAC (heating, ventilation, and air conditioning) markets. Modine's products include engine cooling systems, heat exchangers, and ventilation systems, providing critical thermal solutions for vehicles, data centers, and various equipment worldwide.
Read more on MOD →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
